FDA Approves Rare Pediatric Disease Designation for IMX-110 for Rhabdomyosarcoma

Officials with the FDA have approved a Rare Pediatric Disease Designation for IMX-110 for the treatment of pediatric patients with rhabdomyosarcoma.

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

Researchers turn back the clock on cancer cells to offer new treatment paradigm

Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

Predicting Infection Risk in Childhood Cancer

Researchers find genetic variant contributing to disparities in childhood leukemia risk

Chemotherapy cured my cancer. Years later it likely gave me heart disease.

How Cancer Can Shape Young Patients’ Sense of Identity

Promoting Cardiovascular Health in Adult Survivors of Childhood Cancers

Change in MYCN-driven cell state opens therapeutic window in high-risk neuroblastoma